A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. - Wikidata - wikimedia - TriplyDB

A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.

A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.

http://www.wikidata.org/entity/Q43872841

about

Interventions for bullous pemphigoid Interventions for bullous pemphigoid Severity score indexes for blistering diseases Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study Advances in understanding and managing bullous pemphigoid Guidelines for the management of bullous pemphigoid Why is the center of evidence-based dermatology relevant to Indian dermatology?Bullous pemphigoid and comorbidities: a case-control study in Portuguese patients.Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial.Use of Topical Corticosteroids in Dermatology: An Evidence-based Approach.Mechanisms of Autoantibody-Induced Pathology.Prognostic factors for mortality in patients with bullous pemphigoid: a meta-analysis.Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts.Gestational pemphigoid.Tyrosine kinases in inflammatory dermatologic disease.When inferiority meets non-inferiority: implications for interim analyses.Autoimmune hypocalciuric hypercalcemia unresponsive to glucocorticoid therapy in a patient with blocking autoantibodies against the calcium-sensing receptor Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009.Randomized controlled trials needed for bullous pemphigoid interventions.Treatment of bullous pemphigoid.Treatment of patch-stage mycosis fungoides with topical corticosteroids.Therapy of autoimmune bullous diseases Topical clobetasol for the treatment of toxic epidermal necrolysis: study protocol for a randomized controlled trial Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome Prodromal bullous pemphigoid.Passive transfer of collagen XVII-specific antibodies induces sustained blistering disease in adult mice Bullous pemphigoid treatment review.Canadian consensus statement on the use of intravenous immunoglobulin therapy in dermatology.Herpes zoster in patients with bullous pemphigoid: a population-based case-control and cohort study.Update on the dermatologic use of systemic glucocorticosteroids.Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1.Editorial: evidence-based dermatology in India: problems and prospects.The diagnosis and treatment of autoimmune blistering skin diseases.Pemphigoid diseases: pathogenesis, diagnosis, and treatment.Iatrogenic Cushing's syndrome and topical steroid therapy: case series and review of the literature.Mortality in bullous pemphigoid and prognostic factors in 1st and 3rd year of follow-up in specialized centre in Poland.The management of autoimmunity in patients with cholestatic liver diseases.IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases.Signalling and targeted therapy of inflammatory cells in epidermolysis bullosa acquisita.Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment.

P2860

Q24234527-A9E6EDE1-4E1C-4E78-8737-E67BC9A1AC2B Q24246607-5E77405B-914D-4290-94DB-2C21245F233C Q24604349-E3D83592-2A3D-463C-BD0F-90575122D854 Q24654269-A76B5660-A6F0-4CEE-8ADC-5360029F0D2E Q26766192-A6678CD1-A3C0-4FE2-9FFD-6D26280C3AFE Q28217521-1F38A3AE-8A32-4988-94D9-7D76ED3EB508 Q33526544-C5980CAF-5476-4813-A893-08511AE0FAF5 Q33558563-E0EFB647-95D2-43EB-A730-13F4A80C18CA Q33592137-2E02CC35-1085-489E-9C81-263B68BEC85B Q33737957-EEF5F533-3F7B-459B-8421-6F8BE69E94EC Q33740580-0FD23578-9DB9-4693-B51C-ED09A771BB44 Q33840859-4010DBEE-2266-4DC4-BDDB-37E9C5D07652 Q34067962-578AC94F-5FE9-489E-9345-AE8759A65403 Q34133053-28FA9F48-1D2E-4491-BC5F-6126BE1F033A Q34166503-709F9110-92DA-4FE0-81FA-F1F0613749F0 Q34337738-C058AF8E-3374-427D-B8BA-5B60B77787A1 Q34617181-097ABA2E-9F38-4203-99B8-B9308CAA7F25 Q35073419-064F20A7-D009-49D5-870B-0A2E858B5B0F Q35097273-2164525A-2B2A-4DF4-8B58-AFB0C39CB3D2 Q35106022-24C7A98D-8821-4309-B8EF-E2DE44DF2F67 Q35612014-65F557B8-0EFC-454B-B8A2-807E2885DE8F Q35919150-E5ECB1CF-CE8B-409F-98B3-906ADCA975CF Q35987000-3B6EF68F-1F99-4328-AB59-29F5BB7A0781 Q36367126-E1428A5B-C217-4D59-BEF6-3B86812FA0E5 Q36419683-907C848B-A3C4-4DE2-A4CA-709B6454EA2B Q36639345-C5F1FD08-AE6E-4152-9F32-F6A0240FDAA5 Q36655183-237A7E1B-C09B-4218-A0A5-56334A561CA2 Q36711702-6AA2BB7A-07AF-4BD3-8DE2-EB0FE0D71982 Q36923739-1156E753-FDF1-454F-AD09-2AF69EDE323B Q36986017-69C0772E-10B1-4313-A645-EB4775B8134D Q37591217-15B5BF04-4AEA-408F-A008-B507C518F7AA Q37672182-915E7153-CC2A-4D9A-8B05-8F58F1828476 Q37895468-3B0FE0DA-2C0A-49BF-B1B7-9EBE7052E747 Q37933427-B3BFC8BB-FFF2-4609-930A-921693B9BE4A Q38064920-C3186EAB-8A4A-4481-8340-0A5DDA5C8F3B Q38602702-E884CE33-96B6-4372-82B8-F7D8408EF862 Q38622370-C527D367-9138-4113-8D40-99AF61697C7F Q38640323-81BC69EA-46A3-43F8-9CBD-CD2ABACEF5D3 Q38749755-71671B30-C352-4F3C-974C-F47068DF6541 Q38752194-58B84A2D-A701-4383-BE65-F9B065B9CD93

P2860

A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.

http://www.wikidata.org/entity/Q43872841

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.

@en

A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.

@nl

type

label

A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.

@en

A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.

@nl

prefLabel

A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.

@en

A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.

@nl

P1433

Q43872841-7C8F560E-0D17-4E59-A60A-6ACD46FCF6D3

P1476

Q43872841-4441D781-5922-493B-9708-F6CDC6B126BA

P2093

Q43872841-34F7A58F-6A55-4363-B654-6FC734E78A89

Q43872841-36F7114D-1E02-4554-9BEC-624FA8306D4D

Q43872841-41FF6BED-B4B3-491C-9AA5-72B234215DF8

Q43872841-46C47A9A-043B-45AF-BAE6-CF446E3A4064

Q43872841-5EDE4FD7-FF41-46BC-864E-2DC3FCE0657C

Q43872841-62E36C8B-95E2-44DD-8DFD-1586D16F90FA

Q43872841-850E5545-560A-4123-BCB8-DF35F05B2524

Q43872841-C6E6FFDC-28D6-4EC8-85F9-E7CB3EDF25F4

Q43872841-CFA77789-FAC5-48AF-966C-3C7DEA4E0870

Q43872841-D62DBB16-B4C7-4845-A98C-C1ECE600960A

P304

Q43872841-B970A84F-238D-428F-BDAB-4BA8DB09A3CA

P31

Q43872841-55DAF4FD-C277-487A-9134-6074CCE9F616

P356

Q43872841-9FA08EB4-8087-4449-A4FF-56A49F3E403F

P407

Q43872841-7F715970-C7C2-479A-BD2A-C064DAFDBE35

P433

Q43872841-D509C189-EC2D-4756-A3F7-C0AB66906022

P478

Q43872841-95E56085-62A8-4370-A924-B99F66A26C5E

P577

Q43872841-00BD64A8-A931-496E-93DF-FF150C83A200

P698

Q43872841-9B17C611-899F-4E3E-8084-26A0EEC6E380

P356

P1433

The New England Journal of Medicine

P1476

A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.

@en

P2093

Brigitte Dreno

http://www.w3.org/2001/XMLSchema#string

Bullous Diseases French Study Group

http://www.w3.org/2001/XMLSchema#string

Catherine Picard

http://www.w3.org/2001/XMLSchema#string

Christophe Bedane

http://www.w3.org/2001/XMLSchema#string

Emmanuel Delaporte

http://www.w3.org/2001/XMLSchema#string

Jacques Benichou

http://www.w3.org/2001/XMLSchema#string

Jean-Claude Roujeau

http://www.w3.org/2001/XMLSchema#string

Loic Vaillant

http://www.w3.org/2001/XMLSchema#string

Michel D'Incan

http://www.w3.org/2001/XMLSchema#string

Pascal Joly

http://www.w3.org/2001/XMLSchema#string

P304

321-327

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA011592

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

346

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11821508

http://www.w3.org/2001/XMLSchema#string